Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index; none of the 40 sources its claims cite is checked for support yet.

A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit

Open access

Abstract

The structure of the catalytic subunit of cAMP-dependent protein kinase (PKA-C), a prototype for the protein kinase superfamily, laid the foundation for the development of targeted kinase inhibitors. Here we describe the structure and biophysical characterization of a PKA-C complex with BLU0588, a small PKA-selective inhibitor. The high-resolution crystal structure not only captures the inhibitor’s unusual T-shaped geometry, but also shows how the four rings of BLU0588 serve as surrogates for ATP’s adenosine and phosphate-organizing sites. Each site contains two subsites. BLU0588’s planar azaindole and pyridine rings, which are buried beneath the glycine-rich loop in a hydrophobic shell at the base of the active site cleft, fill the adenine and ribose subsites. In contrast, BLU0588’s indane and pyrrolidine rings fill the phosphate-organizing site. The indane ring occupies the α/β-phosphate organizing site while the pyrrolidine ring fills the Mg/γ-phosphate organizing site. The structure also shows how BLU0588 nucleates an open but stable conformation of the entire hydrophobic architecture of the N- and C-lobes. In addition to potently blocking phosphoryl transfer activity, BLU0588 also abolishes the synergistic high-affinity binding of the physiological pseudosubstrate inhibitor, protein kinase inhibitor. The residence time of BLU0588, measured by surface plasmon residence, contributes to its picomolar affinity and is distinct from H89, a commonly used but more promiscuous PKA inhibitor. These molecular insights provide a valuable framework for dissecting the organization of the active site cleft as well as different strategies for the rational design of more potent and selective kinase inhibitors in general.

Overview

CoChat Summary

TL;DR

BLU0588 is a PKA-selective ATP-competitive inhibitor that binds PKA-C with picomolar affinity, stabilizes an open but more ordered kinase conformation, and abolishes synergistic high-affinity binding of the pseudosubstrate PKI peptide IP20. A 1.55 Å crystal structure shows its four hydrophobic rings occupy the entire ATP-binding cleft, replacing both adenosine and phosphate/Mg²⁺-organizing subsites.

Key findings

  • The 1.55 Å PKA-C:IP20:BLU0588 structure shows BLU0588 buried under the glycine-rich loop: azaindole/pyridine rings occupy the adenine/ribose subsites, while indane/pyrrolidine rings occupy the phosphate/Mg²⁺ subsites. The G-loop is shifted upward in an open but ordered conformation, disrupting the Phe54–Phe187 interaction and the His87–pThr197 hydrogen bond; DFG and αC-helix salt bridge are “in,” classifying BLU0588 as a Type 1 inhibitor.
  • BLU0588 abolishes IP20/PKI binding synergy: ITC gave Kd 3.8 µM for PKI binding to apo PKA-C versus 2.9 µM for BLU0588-bound PKA-C, with cooperativity coefficient σ ≈ 1.3; FP showed no FAM-IP20 binding in the presence of BLU0588. BLU0588 increased Tm from 42.7 ± 0.9 °C to 57.0 ± 0.7 °C (ΔTm ~14 °C), whereas IP20 alone enhanced thermostability by only ~3 °C and AMP-PNP by only ~2 °C (Tm = 44.6 ± 0.8 °C).
  • BLU0588 is potent and slow-off: apparent Ki = 230 ± 10 pM; SPR gave kass = 26 × 10⁶ M⁻¹s⁻¹ ± 1.8 × 10⁶ M⁻¹s⁻¹, kdiss = 5.6 × 10⁻³ s⁻¹ ± 0.7 × 10⁻³ s⁻¹, KD = 0.21 ± 0.01 nM, with 1:1 stoichiometry. Compared with H89, BLU0588 had an 11-fold slower off-rate, 3.2-fold slower on-rate, and 35-fold higher affinity; H89 SPR gave kass = 8.3 × 10⁶ M⁻¹s⁻¹ ± 0.3 × 10⁶ M⁻¹s⁻¹, kdiss = 60 × 10⁻³ s⁻¹ ± 6.4 × 10⁻³ s⁻¹, KD = 7.3 ± 1.1 nM, and H89 increased Tm by ~11 °C versus ~14 °C for BLU0588.
  • BLU0588 nucleates an extended hydrophobic network: the C-tail is ordered, with FDDY residues Phe327 and Tyr330 surrounding the azaindole; the C-spine is preserved, the R-spine is assembled with small shifts, and five highly coordinated waters occupy the active site.

Methods

  • X-ray crystallography: PKA-C:IP20:BLU0588 complex solved to 1.55 Å in space group P212121 (a = 69.5 Å, b = 73.1 Å, c = 76.5 Å), by molecular replacement using PDB ID 1ATP as search model; refinement yielded R-work 0.18 and R-free 0.21.
  • Biophysical and biochemical assays: differential scanning fluorimetry for thermal stability; isothermal titration calorimetry for PKI(5-24) binding; fluorescence polarization with FAM-IP20; coupled spectrophotometric kinase assay with Kemptide and global Morrison equation fit for apparent Ki; surface plasmon resonance with FSS-tagged human PKA-Cα for BLU0588 and H89 kinetics.
  • Samples: murine or human full-length wild-type PKA-Cα expressed in E. coli for crystallization, FP, and DSF; N-terminally FSS-tagged human PKA-Cα expressed in E. coli for Ki determination and SPR.

Limitations

  • Stated in the paper: SPR interactions were strongly influenced by mass transfer limitation; including 5 mM ATP lowered the fit R² to <0.981, suggesting additional effects at high ATP not explained by simple competition; the authors state their goal is not to explain BLU0588 selectivity or design more selective inhibitors; additional kinetic, NMR, MD, SPR, and crystallography experiments are described as underway.
  • Evident from the text: the prediction that BLU0588 hinders RIα binding was not directly tested; the study is structural and in vitro, with no cellular or in vivo efficacy data; the H89 comparison uses prior structural data (PDB ID 1YDT) and SPR data described as a representative experiment of n = 2 experimental setups.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.2536312123

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. Crystal structure of BLU0588-bound PKA-C. (A) Comparison of small molecule PKA-C inhibitors. The surrogate moieties are highlighted: beige for the phosphate-organizing site, tan for the ribose site, and light blue for the adenine site. Binding affinity values were taken from references provided in main text. (B) Overall structure of PKA-C with BLU0588 (yellow) bound in the active site and with IP20 (red) docked to the C-lobe. (C) Zoom of BLU0588 in the active site overlaid with the ATP-bound C-subunit (PDB ID: 1ATP) highlighting G-loop shifting up. (D) Changes of the interaction network nucleated by Thr197 phosphorylation. The increased distances to His87 of the C-helix are highlighted between ATP-bound PKA-C (Left) and the BLU0588-bound structure (Right).
Fig. 1. Crystal structure of BLU0588-bound PKA-C. (A) Comparison of small molecule PKA-C inhibitors. The surrogate moieties are highlighted: beige for the phosphate-organizing site, tan for the ribose site, and light blue for the adenine site. Binding affinity values were taken from references provided in main text. (B) Overall structure of PKA-C with BLU0588 (yellow) bound in the active site and with IP20 (red) docked to the C-lobe. (C) Zoom of BLU0588 in the active site overlaid with the ATP-bound C-subunit (PDB ID: 1ATP) highlighting G-loop shifting up. (D) Changes of the interaction network nucleated by Thr197 phosphorylation. The increased distances to His87 of the C-helix are highlighted between ATP-bound PKA-C (Left) and the BLU0588-bound structure (Right).CC BY · PubMed Central
Fig. 2. Comparison of the AS and phosphate-organizing site of the BLU0588- vs. ATP-bound PKA-C. (A) Left panel: AS of the ATP-bound conformation (PDB ID: 1ATP). Right panel: The same AS of the BLU0588-bound conformation. The hinge residues (Met120-Glu127) as well as Thr183 are highlighted. All the H-bonds are shown with dashed lines, and the hydrophobic surfaces are shown as shells. The hinge point, G125, is marked as a red ball. (B) Left panel: Phosphate-organizing site of the ATP-bound conformation, displays the highly coordinated network of Mg2+ 1 (magenta), Mg2+ 2 (teal), phosphates (red/orange), and waters (gray spheres). The catalytic triad of Asp184, Lys72, and Glu91 is highlighted with a black circle. Right panel: The same Phosphate-organizing site of the BLU0588-bound conformation. The space that Mg2+ 1 occupies when present is depicted as a white disc.
Fig. 2. Comparison of the AS and phosphate-organizing site of the BLU0588- vs. ATP-bound PKA-C. (A) Left panel: AS of the ATP-bound conformation (PDB ID: 1ATP). Right panel: The same AS of the BLU0588-bound conformation. The hinge residues (Met120-Glu127) as well as Thr183 are highlighted. All the H-bonds are shown with dashed lines, and the hydrophobic surfaces are shown as shells. The hinge point, G125, is marked as a red ball. (B) Left panel: Phosphate-organizing site of the ATP-bound conformation, displays the highly coordinated network of Mg2+ 1 (magenta), Mg2+ 2 (teal), phosphates (red/orange), and waters (gray spheres). The catalytic triad of Asp184, Lys72, and Glu91 is highlighted with a black circle. Right panel: The same Phosphate-organizing site of the BLU0588-bound conformation. The space that Mg2+ 1 occupies when present is depicted as a white disc.CC BY · PubMed Central
Fig. 3. B-factors indicate changes of PKA-C:BLU0588 dynamics. (A) The B-factor of IP20 in the ATP-bound conformation. B-factors of the color bar scale range from 20 to 100 for the ATP-bound structure. (B) The B-factor of IP20 in the BLU0588-bound conformation. The P-site is more flexible. B-factors of the color bar scale range from 10 to 70 for the BLU0588-bound structure. (C) C-tail (red) of PKA-C is ordered in the BLU0588-bound conformation. The hydrophobic tethers (CLT, AST, NLT) are shown. The comparison of the B-factors in the C-tails of ATP-bound (D) with BLU0588-bound (E) PKA-C structure. The C-spine (tan or green) and R-spine (red or blue) are highlighted. The C-tail in the BLU0588-bound conformation is much more stable. (F) Alignment of the R-spine residues in the BLU0588-bound (light violet) to the ATP-bound structure (dark purple).
Fig. 3. B-factors indicate changes of PKA-C:BLU0588 dynamics. (A) The B-factor of IP20 in the ATP-bound conformation. B-factors of the color bar scale range from 20 to 100 for the ATP-bound structure. (B) The B-factor of IP20 in the BLU0588-bound conformation. The P-site is more flexible. B-factors of the color bar scale range from 10 to 70 for the BLU0588-bound structure. (C) C-tail (red) of PKA-C is ordered in the BLU0588-bound conformation. The hydrophobic tethers (CLT, AST, NLT) are shown. The comparison of the B-factors in the C-tails of ATP-bound (D) with BLU0588-bound (E) PKA-C structure. The C-spine (tan or green) and R-spine (red or blue) are highlighted. The C-tail in the BLU0588-bound conformation is much more stable. (F) Alignment of the R-spine residues in the BLU0588-bound (light violet) to the ATP-bound structure (dark purple).CC BY · PubMed Central
Fig. 4. BLU0588 nucleates an extensive hydrophobic network of interactions. (A) The hydrophobic residues from the N-lobe (tan), the C-lobe (yellow), and the C-tail (red) surround BLU0588. The C-spine is shown in yellow. In the BLU0588 complex, the hydrophobic shell between Phe54 and Phe187, as well as the H-bond between H87 and pT197, that are present in the ATP-bound conformation, are now broken (marked by red arrow). (B) The hydrophobic surface of the N-lobe (gray) when bound with BLU0588. The hydrophobic residues, Phe54 from the G-loop, Val79 and Leu82 from the B-helix, as well as several residues from the C-tail (red) including Phe327, Tyr330, Phe347, and Phe350 (marked by black arrows) are highlighted.
Fig. 4. BLU0588 nucleates an extensive hydrophobic network of interactions. (A) The hydrophobic residues from the N-lobe (tan), the C-lobe (yellow), and the C-tail (red) surround BLU0588. The C-spine is shown in yellow. In the BLU0588 complex, the hydrophobic shell between Phe54 and Phe187, as well as the H-bond between H87 and pT197, that are present in the ATP-bound conformation, are now broken (marked by red arrow). (B) The hydrophobic surface of the N-lobe (gray) when bound with BLU0588. The hydrophobic residues, Phe54 from the G-loop, Val79 and Leu82 from the B-helix, as well as several residues from the C-tail (red) including Phe327, Tyr330, Phe347, and Phe350 (marked by black arrows) are highlighted.CC BY · PubMed Central
Fig. 5. Biochemical analysis of BLU0588 binding to PKA-C. (A) B-factor comparison of the kinase core between BLU0588-bound (Left) and ATP-bound (Right) PKA-C. B-factors of the color bar scale range from 20 to 100 for the ATP-bound structure and from 10 to 70 for the BLU0588-bound structure. (B) Thermal denaturation profile of PKA-C in the absence (black) and in the presence of BLU0588 (blue). Three different ratios of PKA-C:IP20 [1:10 (pink), 1:20 (orange), and 1:50 (red)] were tested. (C) Histogram representing the Tm (°C) values of PKA-C apo (42 ± 1), with 50 µM BLU0588 (56 ± 1), and at three different molar ratios of PKA-C:IP20, 1:10 (57 ± 1), 1:20 (57 ± 1), and 1:50 (58 ± 2). (D) Determination of the apparent Ki for BLU0588. Phosphorylation of the peptide substrate Kemptide was inhibited by adding BLU0588 with various ATP concentrations as indicated in the legend. Enzyme activities with inhibitor concentrations below 1 µM are enlarged in the inlet (gray background). The apparent Ki was calculated using global fit of the Morrison equation for tight binding inhibitors (see methods). Data fitted globally for 50 µM, 100 µM, 500 µM, and 1 mM ATP yielded an R2 > 0.993; including 5 mM ATP lowered the R2-value to R2 < 0.981, suggesting additional effects at high ATP not explained by a simple competition with ATP/Mg2+. (E) FP assay to analyze the binding of fluorescein-labeled IP20 peptide to PKA-C (0.25 to 512 nM) in buffer containing 10 mM MgCl2 in the presence (●) or absence (■) of 1 mM ATP. Each experiment was tested in triplicate and the data were analyzed with GraphPad Prism9.
Fig. 5. Biochemical analysis of BLU0588 binding to PKA-C. (A) B-factor comparison of the kinase core between BLU0588-bound (Left) and ATP-bound (Right) PKA-C. B-factors of the color bar scale range from 20 to 100 for the ATP-bound structure and from 10 to 70 for the BLU0588-bound structure. (B) Thermal denaturation profile of PKA-C in the absence (black) and in the presence of BLU0588 (blue). Three different ratios of PKA-C:IP20 [1:10 (pink), 1:20 (orange), and 1:50 (red)] were tested. (C) Histogram representing the Tm (°C) values of PKA-C apo (42 ± 1), with 50 µM BLU0588 (56 ± 1), and at three different molar ratios of PKA-C:IP20, 1:10 (57 ± 1), 1:20 (57 ± 1), and 1:50 (58 ± 2). (D) Determination of the apparent Ki for BLU0588. Phosphorylation of the peptide substrate Kemptide was inhibited by adding BLU0588 with various ATP concentrations as indicated in the legend. Enzyme activities with inhibitor concentrations below 1 µM are enlarged in the inlet (gray background). The apparent Ki was calculated using global fit of the Morrison equation for tight binding inhibitors (see methods). Data fitted globally for 50 µM, 100 µM, 500 µM, and 1 mM ATP yielded an R2 > 0.993; including 5 mM ATP lowered the R2-value to R2 < 0.981, suggesting additional effects at high ATP not explained by a simple competition with ATP/Mg2+. (E) FP assay to analyze the binding of fluorescein-labeled IP20 peptide to PKA-C (0.25 to 512 nM) in buffer containing 10 mM MgCl2 in the presence (●) or absence (■) of 1 mM ATP. Each experiment was tested in triplicate and the data were analyzed with GraphPad Prism9.CC BY · PubMed Central
Fig. 6. The conformational, dynamic, and kinetic differences between BLU0588 (A) and H89 (B). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (kass and kdiss) and the experimental Rmax for both inhibitors. Representative experiment of n = 2 experimental setups.
Fig. 6. The conformational, dynamic, and kinetic differences between BLU0588 (A) and H89 (B). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (kass and kdiss) and the experimental Rmax for both inhibitors. Representative experiment of n = 2 experimental setups.CC BY · PubMed Central
Fig. 7. Hydrophobically dominated BLU0588 active site compared to the split electrostatic/hydrophobic active site of ATP-bound PKA-C. (A) The active site of the ATP-bound conformation is split into the hydrophobic AS and the electrostatically charged phosphate-organizing site (PS) (Left). (B) Both the AS and PS sites are hydrophobic with BLU0588 bound to PKA-C. Zoom on the catalytic triad (Asp184, Lys72, Glu91) in both complexes are shown on the Right panels. The hydrophobic residues from N-lobe (tan) and C-lobe (yellow) are shown as shells, both G-loop (gray or cyan) are also highlighted. The black arrow shows the disengagement of Phe54 from Phe187 when bound to BLU0588.
Fig. 7. Hydrophobically dominated BLU0588 active site compared to the split electrostatic/hydrophobic active site of ATP-bound PKA-C. (A) The active site of the ATP-bound conformation is split into the hydrophobic AS and the electrostatically charged phosphate-organizing site (PS) (Left). (B) Both the AS and PS sites are hydrophobic with BLU0588 bound to PKA-C. Zoom on the catalytic triad (Asp184, Lys72, Glu91) in both complexes are shown on the Right panels. The hydrophobic residues from N-lobe (tan) and C-lobe (yellow) are shown as shells, both G-loop (gray or cyan) are also highlighted. The black arrow shows the disengagement of Phe54 from Phe187 when bound to BLU0588.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 24 Not checked · 116 Own results and interpretations

77 more claims

Create a free account to see all 140 claims and to verify the 39 references still open.

See all claims — free account
  • It may state two separate claims as one. 45
  • Probably not a substantial claim. 17

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 64 references

Research works printed but not linked: 3

  1. B. E. Kemp, Peptides and Protein Phosphorylation (CRC Press, 1990).
  2. 10.7554/elife.91506.3 · doi:10.7554/elife.91506.3
  3. 10.1124/mol.56.2.370 · doi:10.1124/mol.56.2.370

Cited by

See all 3

Metadata

Authors
Bruystens, J. G. H., Wu, J., Tan, G., Bertinetti, D., Zenn, H.-M., Zimmermann, B., Chen, L., Köckenberger, J., Massaro, F., Sankaran, B., Walters, M. S., Veglia, G., Ferguson, F. M., Herberg, F. W., & Taylor, S. S.
Affiliations
  • University of California San Diego (US)
  • University of Kassel (DE)
  • Biaffin (Germany) (DE)
  • University of Minnesota (US)
  • Lawrence Berkeley National Laboratory (US)
Corresponding author
Taylor, Susan S.
Venue
Proceedings of the National Academy of Sciences
Published
2026-05-07
Volume
123
Issue
19
Pages
e2536312123-e2536312123
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W7160539317
Cited by
3
References
64
Citations by year
2026: 3
FWCI
3.80
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
HHS | NIH | NIH Office of the Director (T32CA009523, GM130389, CA290129, GM124169)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
protein kinase A, PKA catalytic subunit, ATP-competitive inhibition, active site cleft, glycine-rich loop, phosphoryl transfer, residence time, H89
MeSH terms
Models, Molecular, Protein Conformation, Cyclic AMP-Dependent Protein Kinases, Crystallography, X-Ray, Catalytic Domain, Protein Kinase Inhibitors, Cyclic AMP-Dependent Protein Kinase Catalytic Subunits

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit. https://app.cochat.ai/papers/10.1073/pnas.2536312123
The paper
Bruystens, J. G. H., Wu, J., Tan, G., Bertinetti, D., Zenn, H.-M., Zimmermann, B., Chen, L., Köckenberger, J., Massaro, F., Sankaran, B., Walters, M. S., Veglia, G., Ferguson, F. M., Herberg, F. W., & Taylor, S. S. (2026). A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2536312123

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.